Affordable Access

deepdyve-link
Publisher Website

Butyricicoccus pullicaecorum in inflammatory bowel disease.

Authors
  • Eeckhaut, Venessa
  • Machiels, Kathleen
  • Perrier, Clémentine
  • Romero, Carlos
  • Maes, Sofie
  • Flahou, Bram
  • Steppe, Marjan
  • Haesebrouck, Freddy
  • Sas, Benedikt
  • Ducatelle, Richard
  • Vermeire, Severine
  • Van Immerseel, Filip
Type
Published Article
Journal
Gut
Publisher
BMJ
Publication Date
Dec 01, 2013
Volume
62
Issue
12
Pages
1745–1752
Identifiers
DOI: 10.1136/gutjnl-2012-303611
PMID: 23263527
Source
Medline
Keywords
License
Unknown

Abstract

Patients with inflammatory bowel disease have lower numbers of Butyricicoccus bacteria in their stools. Administration of B pullicaecorum attenuates TNBS-induced colitis in rats and supernatant of B pullicaecorum cultures strengthens the epithelial barrier function by increasing the TER.

Report this publication

Statistics

Seen <100 times